Aedes Aegypti mosquito: the vector behind dengue, yellow fever, and other diseases

18 Jun 2024

Written by Maya Cherian, Public Health Medical Officer
Reviewed by Dr Nick Walsh MD PhD(epi) BScMed(hons) MPH FAFPHM FAChAM

The Aedes Agypti (A. aegypti) mosquito can be found in tropical and subtropical areas worldwide. The A. Aegypti mosquito is a small, dark mosquito that can be identified by the white bands on its legs and a silver-white pattern of scales on its body. The mosquito has been compared to the Greek musical instrument, the lyre (Figure 1).1

Aedes Aegypti Mosquito 1
Aedes Aegypti Mosquito 2
Aedes Aegypti Mosquito 3

Figure 1: Lyre

The mosquito has been compared to the
Greek musical instrument, the lyre.

Lyre

The A. Agypti mosquito comes from the family Culicidea, genus Aedes and Subgenus Stegomyia. It takes approximately 7-10 days for an egg to develop into an adult mosquito (Figure 2).2

Figure 2: A. Aegypti life cycle

Figure 3: Eggs

Female mosquitoes need a small amount of water to lay eggs, laying just above the water line. Eggs are able to survive drying out for months, as well as northern hemisphere winters (Figure 3).2

When water covers the eggs, the eggs hatch into larvae, which live in the water (Figure 4).2

Figure 4: Larvae

Figure 5: Papu

Larvae then develop into pupae (Figure 5),2 which adult mosquitoes emerge from with a total life span of approximately three weeks.

The A. Agypti don’t travel long distances, moving only a few blocks and have a total life span of approximately three weeks.

The A. Aegypti mosquito has historically been found in tropical and subtropical areas in forested areas. Over time geographic spread has increased to include Europe, the Southern Cone of South American and the United States.3 With urbanisation, the mosquito can survive in a wide range of artificial containers, adapting to both indoor and outdoor aquatic container habitats.

Disease transmission

The A. Aegypti mosquito is the vector for dengue, yellow fever, chikungunya and Zika virus (Table 1).4 It has been identified as a potential vector for Venezuelan equine encephalitis virus and studies have shown it is capable of transmitting West Nile virus.4

Summary of diseases transmitted by Aedes Aegypti mosquito

Dengue

Virus
Genus: Flavivirus.


Epidemiology

DENV is endemic in the tropics and subtropics. Dengue cases have significantly increased globally. Since January 2024, there have been over 5 million reported cases and over 2000 deaths globally.5 Asia represents 70% of the global disease burden.


Clinical presentation

Dengue is commonly referred to as break bone fever, due to the fever and muscle and joint pain associated with infection. Presentations are characterised by three phases, febrile, critical and convalescent phase.


Treatment

No treatment currently available.


Prevention

Avoid mosquito bites.

Dengvaxia®6is currently the only available vaccine in the world, available for the prevention of secondary dengue.

Yellow fever

Virus
Genus: Flavivirus.


Epidemiology

Sub-Saharan Africa and tropical South America.

As of 25 Feb 2024, 13 countries in World Health Organization (WHO) African region have probable and confirmed cases


Clinical presentation

Asymptomatic

Common symptoms: fever, muscle pain with prominent back pain, headache, loss of appetite, nausea or vomiting.

Few cases (~12%)8 progress to systemic infection leading to acute liver and kidney failure.


Treatment

No treatment currently available.


Prevention

Vaccine preventable.

Single vaccine provides life-long immunity within 10 days (80-100%) and within 30 days (99%).7

Avoid mosquito bites.

Chikungunya

Virus

Family: Togaviridae,
Genus: Alphavirus.


Epidemiology

Occurs in tropical and subtropical regions.

Cases involve large outbreaks with high attack rates, affecting up to 75% of the population where virus is circulating.

Outbreaks occur during topical rainy season.


Clinical presentation

Up to 28% of cases remain asymptomatic.

Clinical symptoms include fever lasting up to 1 week and joint pain, most commonly occurring in the hands and feet. Other symptoms include headache, conjunctivitis, myalgia, nausea, vomiting or rash.

Serious complications includes hepatitis, myocarditis, neurological disease, ocular disease, renal disease and severe skin lesions.


Treatment

No treatment currently available.


Prevention

IXCHIQ approved by US FDA10 for individuals under 18 years old at increased risk of exposure to chikungunya virus.

Avoid mosquito bites.

Not approved for use in Australia.

Zika virus

Virus
Family: Flaviviridae,
Genus Flavivirus.


Epidemiology

Tropical and subtropical regions.

Since 2007, outbreaks have occurred throughout the Pacific Islands and Southeast Asia.

In 2015, there was a large outbreak throughout the Americas.


Clinical presentation

Asymptomatic or mild.

Symptoms include fever, arthralgia, non-purulent conjunctivitis and maculopapular rash.

Hospitalisation and death are uncommon.

Vertical transmission can lead to congenital Zika virus infection, leading to microcephaly with brain anomalies and foetal loss.


Treatment

No treatment currently available.


Prevention

No vaccine or preventable medication currently available.

Avoid mosquito bites.

Climate change and the Aedes Aegypti mosquito

There have been ongoing concerns for many years on the effects of climate change on mosquito populations. Without reductions in greenhouses gases, temperatures will continue to rise, favouring the development of new mosquito development.12 The prevalence of vector-borne diseases has increased with malaria, dengue, lyme disease and West Nile virus infection expected to further rise if appropriate control strategies are not implemented.13 Surveillance and control form the basis of community and household or individual adaptation strategies to respond to vector-borne diseases with adaptation measures required to decrease the impact of such diseases.13

Nejmra2200092 F3

Novel methods for decreasing transmission

The World Mosquito Program (WMP) is a not-for-profit group14 led by Monash University. The WMP is leading research into preventing the transmission of vector-borne diseases using Wolbachia. Wolbachia is an intracellular bacterium safe for humans and the environment that naturally occurs in 50% of arthopod (including insects) species. Its presence upregulates host immune mechanisms, resulting in an ‘antiviral’ effect. A. Aegypti does not normally carry Wolbachia; however, other mosquitoes do. Wolbachia blocks the growth of viruses such as dengue, yellow fever, chikungunya, and Zika in A. Aegypti mosquitoes. Wolbachia mosquitoes have been released at a number of sites in northern Australia over the past decade and more recently overseas, resulting in the replacement of the mosquito population and a decreased dengue incidence by 77% and dengue hospitalisation by 86%. Food chains or population size are not decreased by Wolbachia.

Crop Maya Profile Image

Dr Maya Cherian
Public Health Physician

Maya is a Public Health Physician, joining NCCTRC as a registrar in 2023. Maya has experience in Aboriginal health, public policy, communicable diseases, statistics and health economics. Maya is excited to contribute to the fabric of the organisation and assist in enhancing the public health components of NCCTRC, through education, research and policy.
Next news
Latest news
Stop the spread of syphilis. Tell your physician from whom you got it. Treatment will benefit them and prevent it's spread. Ben Kaplan

Understanding syphilis: a curable yet rising threat

1O3A7371

Building a resilient future: insights from the 6th EMT Global Meeting

National Critical Care And Trauma Response Centre

A snapshot of AUSMAT by the numbers

Image: Mpox. Source: Nigeria Centre for Disease Control and Prevention

Mpox transmission and control: understanding the virus and global response

20230822 GOARN

GOARN initiates leadership training to empower women in global health and emergency response

 DSC0904a

Exertional heat stroke treatment in austere settings

Previous stories
0Y4A3223

Project launch: enhancing AUSMAT’s surgical cache for future deployments

Image000001

Republic of Indonesia Defence University (RIDU) Multi-Country Training Hub for Health Emergency Operational Readiness

Rabies publicity posters – Royal Veterinary College

Rabies’ global impact and the fight for Zero by 2030

0Y4A9918

A year in the life of a RRT clinical nurse specialist

IMG 3429

Gaining global attention: Capacity building in the Pacific